snyderman nancy lynn MD
Insider CIK 1675198 · LYRA Director · ALKS Director · AXNX Director · FHLT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALKS Alkermes plc. | M Exercise deriv | 2026-08-03 | 2026-08-03 | 16,524 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2026-08-03 | 2026-08-03 | 27,948 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2026-08-03 | 2026-08-03 | 27,948 | $46.72 | $1.31M | 43,343 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2026-08-03 | 2026-08-03 | 16,524 | $46.72 | $772.0K | 59,867 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2026-08-03 | 2026-08-03 | 44,472 | $50.35 | $2.24M | 15,395 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2026-08-03 | 2026-08-03 | 16,524 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2026-08-03 | 2026-08-03 | 27,948 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2026-08-03 | 2026-08-03 | 44,472 | $50.35 | $2.24M | 15,395 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2026-08-03 | 2026-08-03 | 16,524 | $46.72 | $772.0K | 59,867 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2026-08-03 | 2026-08-03 | 27,948 | $46.72 | $1.31M | 43,343 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2026-05-21 | 2026-05-22 | 1,475 | $36.95 | $54.5K | 15,395 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 16,870 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2025-05-31 | 2025-06-02 | 1,924 | $30.61 | $58.9K | 10,728 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 12,652 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2025-05-21 | 2025-05-23 | 6,142 | — | $0 | 6,142 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2025-05-21 | 2025-05-23 | 13,474 | — | $0 | 13,474 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2025-05-14 | 2025-05-16 | 32,000 | — | $0 | 32,000 | SEC↗ |
| AXNX Axonics, Inc. | D To issuer deriv | 2024-11-15 | 2024-11-15 | 10,000 | $49.96 | $499.6K | 0 | SEC↗ |
| AXNX Axonics, Inc. | D To issuer deriv | 2024-11-15 | 2024-11-15 | 4,167 | $36.90 | $153.8K | 0 | SEC↗ |
| AXNX Axonics, Inc. | D To issuer | 2024-11-15 | 2024-11-15 | 14,944 | $71.00 | $1.06M | 0 | SEC↗ |
| AXNX Axonics, Inc. | G Gift | 2024-11-07 | 2024-11-12 | 5,000 | — | $0 | 14,944 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2024-06-29 | 2024-07-01 | 6,104 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2024-06-29 | 2024-07-01 | 1,465 | $24.10 | $35.3K | 4,639 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2024-06-29 | 2024-07-01 | 6,104 | — | $0 | 6,104 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2024-05-31 | 2024-06-04 | 17,492 | — | $0 | 17,492 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2024-05-31 | 2024-06-04 | 8,013 | — | $0 | 8,013 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 284 | $57.11 | $16.2K | 14,484 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 324 | $46.72 | $15.1K | 16,524 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 548 | $46.72 | $25.6K | 27,948 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 119 | — | $0 | 6,104 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 254 | $30.72 | $7.8K | 12,986 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 231 | $30.86 | $7.1K | 11,785 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 313 | $24.24 | $7.6K | 15,990 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 230 | $18.45 | $4.2K | 11,739 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 256 | $16.52 | $4.2K | 13,079 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 448 | $24.55 | $11.0K | 22,848 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 350 | $44.75 | $15.7K | 17,850 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2023-07-07 | 2023-07-10 | 5,957 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2023-07-07 | 2023-07-10 | 1,430 | $29.88 | $42.7K | 20,783 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2023-07-07 | 2023-07-10 | 5,957 | — | $0 | 22,213 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2023-06-29 | 2023-06-30 | 5,985 | — | $0 | 5,985 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2023-06-29 | 2023-06-30 | 12,732 | — | $0 | 12,732 | SEC↗ |
| AXNX Axonics, Inc. | A Award | 2023-06-26 | 2023-06-28 | 3,000 | — | $0 | 19,944 | SEC↗ |
| AXNX Axonics, Inc. | A Award | 2022-08-18 | 2022-08-22 | 2,100 | — | $0 | 16,944 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2022-07-07 | 2022-07-08 | 5,957 | — | $0 | 5,957 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2022-07-07 | 2022-07-08 | 11,554 | — | $0 | 11,554 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-21 | 7,250 | — | $0 | 7,250 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2022-06-14 | 2022-06-16 | 7,585 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2022-06-14 | 2022-06-16 | 695 | $27.19 | $18.9K | 16,256 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2022-06-14 | 2022-06-16 | 7,585 | — | $0 | 16,951 | SEC↗ |
| ALKS Alkermes plc. | P Buy | 2022-03-04 | 2022-03-08 | 427 | $23.43 | $10.0K | 9,366 | SEC↗ |
| ALKS | M Exercise deriv | 2021-12-02 | 2021-12-03 | 5,578 | — | $0 | 0 | SEC↗ |
| ALKS | M Exercise | 2021-12-02 | 2021-12-03 | 5,578 | — | $0 | 10,278 | SEC↗ |
| ALKS | F Tax w/h | 2021-12-02 | 2021-12-03 | 1,339 | $22.11 | $29.6K | 8,939 | SEC↗ |
| FHLT Future Health ESG Corp. | D To issuer | 2021-10-24 | 2021-10-26 | 1,689 | — | $0 | 11,262 | SEC↗ |
| FHLT Future Health ESG Corp. | D To issuer | 2021-10-24 | 2021-10-26 | 1,688 | — | $0 | 11,250 | SEC↗ |
| AXNX Axonics, Inc. | A Award | 2021-10-22 | 2021-11-02 | 2,261 | — | $0 | 14,844 | SEC↗ |
| FHLT Future Health ESG Corp. | P Buy deriv | 2021-09-14 | 2021-09-16 | 27,351 | $1.00 | $27.4K | 27,351 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2021-06-14 | 2021-06-16 | 15,677 | — | $0 | 15,677 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2021-06-14 | 2021-06-16 | 7,585 | — | $0 | 7,585 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2021-05-26 | 2021-05-28 | 7,250 | — | $0 | 7,250 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2021-05-20 | 2021-05-21 | 6,104 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2021-05-20 | 2021-05-21 | 6,104 | — | $0 | 6,104 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2021-05-20 | 2021-05-21 | 1,404 | $21.92 | $30.8K | 4,700 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2020-12-16 | 2020-12-17 | 1,025 | $9.72 | $10.0K | 1,025 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-12-02 | 2020-12-04 | 11,509 | — | $0 | 11,509 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-12-02 | 2020-12-04 | 5,578 | — | $0 | 5,578 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2020-10-27 | 2020-10-29 | 14,500 | — | $0 | 14,500 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award | 2020-08-24 | 2020-08-26 | 3,500 | — | $0 | 12,583 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-05-20 | 2020-05-22 | 6,104 | — | $0 | 6,104 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-05-20 | 2020-05-22 | 12,823 | — | $0 | 12,823 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award deriv | 2019-08-22 | 2019-08-26 | 4,167 | — | $0 | 4,167 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award | 2019-08-22 | 2019-08-26 | 2,083 | — | $0 | 9,083 | SEC↗ |
| AXNX Axonics Modulation Technol | P Buy | 2019-06-27 | 2019-07-01 | 2,000 | $37.12 | $74.2K | 7,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2019-05-22 | 2019-05-23 | 22,400 | — | $0 | 22,400 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award deriv | 2019-04-08 | 2019-04-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award | 2019-04-08 | 2019-04-09 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2018-05-23 | 2018-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2017-05-24 | 2017-05-25 | 14,200 | — | $0 | 14,200 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2016-09-14 | 2016-09-15 | 16,200 | — | $0 | 16,200 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2016-09-14 | 2016-09-15 | 27,400 | — | $0 | 27,400 | SEC↗ |